Celldex Therapeutics (CLDX) Gross Margin (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Gross Margin of 9620.0% for Q1 2026, down 940806.0% year-over-year from N/an in Q1 2025, and down 951.51% quarter-over-quarter from 914.88% in Q4 2025.
Celldex Therapeutics (CLDX) Gross Margin (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Gross Margin history runs 7 years deep, the most recent figure standing at 9620.0% for Q1 2026.
- In Q1 2026, Gross Margin fell 940806.0% year-over-year to 9620.0%; the TTM figure through Mar 2026 stood at 510.51% (down 52490.0% YoY), while the FY2025 annual figure was 288.16%, down 30823.0% from the prior year.
- Gross Margin for Q1 2026 stood at 9620.0%, down from 914.88% in the prior quarter.
- The five-year high for Gross Margin was 66.34% in Q3 2024, with the low at 9620.0% in Q1 2026.
- The 3-year median for Gross Margin is 161.72% (2025), against an average of 1441.56%.
- The sharpest annual moves came in 2025 and 2026: Gross Margin soared 52652 bps in 2025, then slumped 940806 bps in 2026.
- Celldex Therapeutics' Gross Margin stood at 37.36% in 2024, then slumped by 2349 bps to 914.88% in 2025, then slumped by 952 bps to 9620.0% in 2026.
- Business Quant data shows CLDX's Gross Margin at 9620.0% in Q1 2026, 914.88% in Q4 2025, and 111.51% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | -11,686.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11,686.36% |
| Mar 31, 2026 | -9,620.00% |
| Dec 31, 2025 | -914.88% |
| Jun 30, 2025 | -111.51% |
| Mar 31, 2025 | -211.94% |
| Dec 31, 2024 | -37.36% |
| Sep 30, 2024 | 66.34% |
| Jun 30, 2024 | 35.35% |
| Mar 31, 2024 | -738.46% |
| Dec 31, 2013 | 100.00% |
| Sep 30, 2013 | 100.00% |
| Jun 30, 2013 | 100.00% |
| Mar 31, 2013 | 3.31% |
| Dec 31, 2012 | 2.63% |
| Sep 30, 2012 | 3.44% |
| Jun 30, 2012 | 6.77% |
| Mar 31, 2012 | 3.66% |
| Dec 31, 2011 | 3.08% |
| Sep 30, 2011 | 1.90% |
| Jun 30, 2011 | 0.56% |